| Health / Medical Topics |
anti-PDGFR alpha monoclonal antibody IMC-3G3
Pronunciation
A substance being studied in the treatment of glioblastoma (a type of brain tumor) that has come back. It binds to receptors for a protein called platelet-derived growth factor (PDGF). This keeps PDGF from binding to the cells. This may stop the growth of cancer cells and blood vessels that have the receptors for PDGF. It is a type of monoclonal antibody. Also called anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3 and IMC-3G3. (NCI Dictionary)
YOU MAY ALSO LIKE
A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1) with potential immunomodulating and antineoplastic…
A fully human monoclonal antibody directed against the protein ligand PD-L1 (Programmed Death-1 Ligand 1) with immunomodulating and potential antineoplastic activities. Anti-PD-L1…
A monoclonal antibody directed against the human programmed cell death 1 (PD-1) protein, with potential immunomodulating and antineoplastic activity. Although the exact…
An Fc-fusion protein containing a ligand of programmed death-1 (PD-1), with potential immunomodulating and antineoplastic activity. Anti-PD-1 fusion protein AMP-224 blocks the…
Human autologous peripheral blood lymphocytes (PBLs) transduced with an anti-p53 T cell receptor gene with potential antineoplastic activity. PBLs are harvested from…
An agonistic monoclonal antibody against receptor OX40 (CD134), with potential immunostimulatory activity. Mimicking the natural OX4 ligand (OX40L), anti-OX40 monoclonal antibody selectively…
